EP2797601
PHARMACEUTICAL COMPOSITIONS TO REDUCE COMPLICATIONS OF OCULAR STEROID
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
8.2.2013EP published:
21.3.2018EP application number:
13747021.7
EPO information:
European Patent Register
Max expiry date:
7.2.2033
Title:
PHARMACEUTICAL COMPOSITIONS TO REDUCE COMPLICATIONS OF OCULAR STEROID
Timeline
Today
8.2.2013EP application
21.3.2018EP Publication
Owner
Name:
Taiwan Liposome Company, Ltd.Address:
11F-1 No 3 Yuanqu Street Nangang District, Taipei City, TW
Name:
TLC Biopharmaceuticals, Inc.Address:
432 North Canal Street 20, 94080, South San Francisco, CA, US
Inventor
Name:
HONG, KeelungAddress:
South San Francisco, California, US
Name:
GUO, Luke S.S.Address:
South San Francisco, California, US
Name:
TSENG, Yun-LongAddress:
Taipei City, TW
Name:
SHIH, Sheue-FangAddress:
Taipei City, TW
Name:
CHANG, Po-ChunAddress:
Taipei City, TW
Name:
TSAI, Chih-ChiangAddress:
Taipei City, TW
Name:
LIN, Hong-HuiAddress:
Taipei City, TW
Priority
Number:
201261597189 PDate:
10.2.2012Country:
US
Classification
Categories:
A61K 31/661, A61K 31/685, A61K 31/56, A61K 9/08, A61P 27/02